Skip to main content
Year archive

KANGSTEM BIOTECH CO., LTD. — 2019 filings

All 39 regulatory filings released by KANGSTEM BIOTECH CO., LTD. (217730) in 2019, sourced directly from the official regulator.

39 Filings
2019 Period
2019 filings (39)
Filing Released Lang
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2019-12-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-12-09 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2019-12-09 Korean
분기보고서 (2019.09)
Interim / Quarterly Report 9M 2019
2019-11-13 Korean
기타경영사항(자율공시)(전환가액 조정(전환우선주))
Capital/Financing Update
2019-11-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-11-05 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2019-11-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-10-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-10-30 Korean
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Share Issue/Capital Change
2019-10-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-10-28 Korean
투자판단관련주요경영사항(아토피피부염(퓨어스템-에이디주)임상3상 통계분석결과)
Legal Proceedings Report
2019-10-24 Korean
기업설명회(IR)개최
Investor Presentation
2019-10-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-10-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2019-09-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-09-09 Korean
최대주주변경을수반하는주식담보제공계약체결
Share Issue/Capital Change
2019-09-06 Korean
반기보고서 (2019.06)
Interim / Quarterly Report H1 2019
2019-08-14 Korean
기타경영사항(자율공시)(전환가액 조정 (전환우선주))
Capital/Financing Update
2019-08-12 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2019-07-11 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update
2019-07-03 Korean
[기재정정]사업보고서 (2018.12)
Audit Report / Information FY 2018
2019-06-28 Korean
유상증자결정(종속회사의주요경영사항)(제3자배정)
Share Issue/Capital Change
2019-06-14 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2019-06-05 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Q1 2019
2019-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-04-16 Korean
사업보고서 (2018.12)
Annual Report FY 2018
2019-04-01 Korean
투자판단관련주요경영사항(제대혈 유래 줄기세포 아토피피부염 치료제 국내 독점판권/통상실시권 설정 및 기술전수 계약 체결)
Capital/Financing Update
2019-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2019-03-21 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2019-03-21 Korean
감사보고서제출
Audit Report / Information FY 2018
2019-03-13 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2019-03-05 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2019-03-05 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2019-03-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2019-02-20 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2019-02-19 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2019-02-18 Korean
기타경영사항(자율공시)(공동개발계약 변경 합의)
Regulatory Filings
2019-02-15 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports
2019-01-25 Korean